Aignostics
aignostics.com
Actively hiring
Computer Vision
Medical AI
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$34M
5 rounds on record
Latest round
$34M
Series B · Nov 2024 · 23 mo ago
Team
51-200
employees, estimated range
Grants
$3.3M
4 grants · CORDIS
Backers
2
High-Tech Gründerfonds, IBB Ventures
The money's age
Due for its next round
23 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 12
Launched Aignostics Launches PathoSearch, a Visual Search Engine for Pathology Cases · PRNewswire
Sep 12
Partnership Aignostics Joins Techcyte Fusion Partner Program to Bring PathoSearch to Fusion AP · dispatch.com
Jun 9
Partnership Aignostics Partners with the Pancreatic Cancer Action Network to Advance Pancreatic Cancer Research · morningstar.com
Oct 15, 2025
Launched Aignostics Launches AI-Powered Application for Tumor Microenvironment Profiling · YahooFinance
Mar 1, 2025
Won a grant $1.4M · CORDIS
Nov 3, 2024
Raised a round Series B $34M · Pulse 2.0
Sep 1, 2024
Won a grant $1.1M · CORDIS
Jul 1, 2023
Won a grant $683k · CORDIS
Sep 1, 2021
Won a grant $130k · CORDIS
2018
Founded
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Funding rounds
Registers and programsofficial lists and records that name the company
| Legal entity | Aignostics GmbH | its site |
Founders and leadersfrom filings, registers and the company's site
Viktor MatyasVertreten durchcompany's site
Backed byfrom the funds' portfolios and accelerator catalogs
High-Tech Gründerfonds 
IBB Ventures Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Pictor Labs is The Virtual Staining Company enabling digital pathology adoption through computational virtual staining technology that…
Franklin.ai develops artificial intelligence software for digital pathology. Its algorithms assist pathologists in grading and detecting…
Qure.ai is a Computer Software company that offers deep learning & AI-based solutions to diagnose disease from radiology and pathology…
mediaire is a Berlin company founded in 2018 that automates the analysis of brain and spine magnetic resonance images. Its mdbrain software…
Harrison.ai is an Australian medical artificial intelligence company founded in Sydney in 2018 by the physician Aengus Tran and his brother…
ACES builds deep learning systems for video understanding and business process digitisation. Its models analyse human behaviour in sales…
Overview
Aignostics is a Berlin company founded in 2018 as a spin-out from the Charité hospital and its artificial intelligence institute. Its pathology foundation models analyse tissue images to support drug development and diagnostics. The company works with pharmaceutical partners on biomarker discovery from digitised slides.
News
Aignostics Launches PathoSearch, a Visual Search Engine for Pathology Cases
Today, Aignostics announced the early access release of PathoSearch, a visual search engine for pathology cases. From a single screenshot of a region of interest on an H&E slide, PathoSearch instantly retrieves morphologically similar, diagnosed reference
Read more
Report
Aignostics Launches PathoSearch, a Visual Search Engine for Pathology Cases
/PRNewswire/ -- Today, Aignostics announced the early access release of PathoSearch, a visual search engine for pathology cases. From a single screenshot of a...
Read more
Report
Aignostics leads latest crop of digital health financings
Our round-up of funding rounds in the digital health arena features Aignostics, TCC, Yazen Health, Nema Health, Alimetry, and Research Grid.
Read more
Report
Aignostics Partners with the Pancreatic Cancer Action Network to Advance Pancreatic Cancer Research
Collaboration will apply Aignostics' AI-technology to PanCAN's multimodal pancreatic cancer dataset, with results made broadly accessible to both academic and life sciences researchers.LOS ANGELES
Read more
Report
Aignostics Partners with the Pancreatic Cancer Action Network to Advance Pancreatic Cancer Research
Read more
Report
Aignostics Announces New State-of-the-Art Pathology Foundation Model
/PRNewswire/ -- Today, Aignostics announced research results for Atlas 2, an updated version of its pathology foundation model. Built in collaboration with...
Read more
Report
Aignostics Announces New State-of-the-Art Pathology Foundation Model
Atlas 2 sets new industry standard and achieves best-in-class performance and computational efficiencyBERLIN and NEW YORK, Jan. 13, 2026 /PRNewswire/ -- Today, Aignostics announced research
Read more
Report
Aignostics Launches AI-Powered Application for Tumor Microenvironment Profiling
Following successful early access pilots with leading biopharma partners, Aignostics today announced the general availability of Atlas H&E-TME, an application for analyzing the tumor microenvironment (TME) in H&E images. Atlas H&E-TME addresses a critical
Read more
Report
Aignostics: $34 Million (Series B) Raised To Turn Complex Pathology Data Into Transformative Insights
Aignostics - a global AI company that turns complex multi-modal pathology data into transformative insights - announced that it has raised $34 million in Series B financing. This additional funding will be used for building new product offerings for bioph
Read more
Report
Show more news
People
Viktor Matyas
Vertreten durch
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Growth
Hiring Momentum
42/100
Stable
Open positions
0
0 opened / 1 closed in 30 days
Median time-to-fill
140 days
faster than 10% of the market
ATS activity
Every ~1 days
Today
Hiring Dynamics
+100%
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Berlin
Germany
HQ
50-200 est. staff